| Cohort 1 | |||||
---|---|---|---|---|---|---|
 | Control | HighCa | NFDM | |||
Lipid analyte (nM) | Mean | SEM | Mean | SEM | Mean | SEM |
∑MAG | ||||||
1-AG | 2.758 | 0.1366a | 3.096 | 0.1573a,b | 3.599 | 0.1214b |
2-AG | 5.718 | 0.3126a | 5.553 | 0.3529a | 8.841 | 0.3825b |
1-LG | 7.147 | 0.1388a | 7.606 | 0.1195a | 8.369 | 0.228b |
2-LG | 7.929 | 0.1191a | 8.235 | 0.09149a | 9.005 | 0.1418b |
1-OG | 7.626 | 0.09071a | 8.196 | 0.1491a,b | 8.287 | 0.2314b |
2-OG | 25. 51 | 2.242a | 33. 74 | 2.376a,b | 37. 31 | 4.725b |
∑NAE | ||||||
DGLEA | 0.4023 | 0.04208a,b | 0.437 | 0.04364a | 0.2798 | 0.02968b |
LEA | 22. 84 | 12. 06a | 7.488 | 3.736a | 2.368 | 1.181b |
mRNA abundance (%) | ||||||
Adipose | ||||||
Cnr1 | 100 | 9.8a | 91. 3 | 10. 8a,b | 63. 8 | 3.7b |
Cnr2 | 100 | 13. 9a | 130.3 | 13. 0a | 54. 3 | 10. 7b |
Mgll | 100 | 10. 4a | 71. 1 | 5.8b | 78. 2 | 5.3a,b |
Liver | ||||||
Pnpla2 | 100 | 8.4a | 254.9 | 49. 8b | 234.2 | 42. 7a,b |